Companies: 10,795·Total market cap: $144.5T
Caribou Biosciences, Inc.

Caribou Biosciences, Inc.

CRBUNASDAQHealthcare● Active
$1.65
+$0.05(+3.13%)
Market Cap$163152046
P/E Ratio
52W High$3.535
52W Low$1.04
Overview

Caribou Biosciences, Inc.(CRBU)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CRBU · 截至 2026-06-15

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($148.13M)($149.10M)($102.07M)($99.42M)($66.92M)
Depreciation & Amort.$3.65M$3.93M$3.52M$3.64M$0.98M
Stock-Based Comp.$12.68M$16.71M$13.75M$0.00M$3.45M
Change in Working Capital($0.48M)($5.11M)($7.32M)($4.11M)$29.07M
Net Cash from Operations($110.99M)($138.20M)($93.29M)($90.97M)($32.52M)
Investing Activities
Capital Expenditure($1.36M)($6.50M)($11.61M)($6.45M)($3.12M)
Purchases of Investments($150.37M)($304.39M)($394.76M)($339.06M)($173.28M)
Sales of Investments$252.83M$397.49M$338.19M$252.87M$0.00M
Net Cash from Investing$102.24M$86.61M($68.18M)($93.25M)($176.40M)
Financing Activities
Common Stock Repurchased$0.00M$0.00M$0.00M$0.00M$0.00M
Dividends Paid$0.00M$0.00M$0.00M$0.00M$0.00M
Debt Issued / Repaid$0.00M$0.00M$0.00M$0.00M$1.03M
Net Cash from Financing$4.82M$16.72M$154.30M$2.13M$433.43M
Free Cash Flow
Free Cash Flow($112.35M)($144.71M)($104.90M)($97.42M)($35.64M)
FCF Margin %(computed)-304.27%-703.34%-371.33%

数据来源:Financial Modeling Prep · 最后更新:2026-06-15 · USD · M

深入了解Caribou Biosciences, Inc.

关于Caribou Biosciences, Inc.(CRBU)现金流量表

Caribou Biosciences, Inc. 2025财年经营活动现金流($0.11B),自由现金流($0.11B)(FCF利润率-1006.82%),资本支出($0.00B)。

常见问题

CRBU · 4 问

Caribou Biosciences, Inc. 2025财年自由现金流($0.11B),同比up22.4%。

CRBU free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15